Ketamine: From Abused Drug to Rapid-Acting Antidepressant
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data from recreational ketamine users show that long-term ketamine use can lead to renal and bladder toxicity, cognitive impairment, dependence, and induced suicidal ideation during withdrawal [101,102].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [102]
Citations
Cites
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Cited by
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“Data from recreational ketamine users show that long-term ketamine use can lead to renal and bladder toxicity, cognitive impairment, dependence, and induced suicidal ideation during withdrawal [101,102].”
Background
Metadata
- Authors
- Hashimoto, K., Ide, S., & Ikeda, K.
- Affiliations
- Chiba University (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Venue
- Springer eBooks
- Publisher
- Springer Singapore
- Published
- 2020
- OpenAlex
- W4235580985
- Cited by
- 6
- References
- 1
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2021: 1
- FWCI
- 1.00
- Type
- book
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, depression, ketamine abuse, mechanism of action, antidepressant efficacy, mental illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine: From Abused Drug to Rapid-Acting Antidepressant. https://app.cochat.ai/papers/10.1007/978-981-15-2902-3
- The paper
- Hashimoto, K., Ide, S., & Ikeda, K. (2020). Ketamine: From Abused Drug to Rapid-Acting Antidepressant. Springer eBooks. https://doi.org/10.1007/978-981-15-2902-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.